Soares, Meyer complete phase II of study on psilocybin
Results of a Phase II trial studying a synthetic form of psilocybin for treatment-resistant depression, which included co-investigators Jair C. Soares, MD, PhD, Pat Rutherford Jr. Chair; and Thomas D. Meyer, PhD, LP, professor, from the Louis A. Faillace, MD,…
Pages